Can a common drug slow brain tumor growth? new study investigates
NCT ID NCT07387666
First seen Feb 04, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This early-phase study looks at how Acetadote, a drug that affects cell damage, changes metabolism in patients with newly diagnosed glioblastoma. Ten adults will receive Acetadote before surgery, and researchers will use MRI scans and tumor tissue analysis to measure metabolic changes. The goal is to understand if this drug can slow tumor growth, not to treat the disease directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Contact
Conditions
Explore the condition pages connected to this study.